Pharvaris
Pharvaris is a late-stage biotech company focused on developing bradykinin B2 receptor antagonists to treat bradykinin-mediated diseases, particularly angioedema. We cater to patients experiencing severe swelling attacks, and our mission is to provide innovative and convenient treatment options that significantly enhance patients' quality of life.
No jobs found. Subscribe below to get notified when we find something for you.
Searching